Scott M. Lippman, MD, Named New Director of UC San Diego Moores Cancer Center

Get Permission


Scott M. Lippman, MD, has been named Director of Moores Cancer Center at the University of California, San Diego, effective May 1, 2012. Dr. Lippman was previously Chair of Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, in Houston.

“As the new director, Dr. Lippman will implement strong initiatives for ramping up the research-driven cancer therapy and prevention programs and clinical trials of the Moores Cancer Center,” said David A. Brenner, MD, vice chancellor for Health Sciences and dean of the School of Medicine at UC San Diego.  “His ultimate goal, and ours, is to facilitate the translation of novel discoveries from our world-class laboratories into personalized therapies.  I am confident that under Dr. Lippman’s leadership, research at Moores Cancer Center will benefit our patients and change standards of care for decades to come.”

Dr. Lippman received his medical degree from Johns Hopkins University School of Medicine, and performed his internship and residency training at Johns Hopkins Hospital and Harbor-UCLA Medical Center. Dr. Lippman received hematology/medical oncology training at Stanford University and the University of Arizona. He is board-certified in internal medicine, hematology and medical oncology.

Dr. Lippman’s major fields of research are translational/molecular studies of cancer risk, molecular-targeted drug development and personalized therapy, with a long-standing record of funding from the NCI in these research areas, including recently as principal investigator of two program project (P01) grants and a Specialized Program of Research Excellence (SPORE). He is also leader of the Lung Cancer Program of the MD Anderson Cancer Center Support Grant and is co-investigator on the American Association for Cancer Research (AACR) Stand Up to Cancer (SU2C) project involving molecular studies of lung cancer.

The University of California, San Diego, Moores Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer centers and it is part of the UC San Diego Health System. ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.